Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Very few sellers of TLT stock

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 27, 2022 8:04am

167 Views

Post# 34853133

RE:RE:RE:Very few sellers of TLT stock

Scorpio ... Yep. You described the forces at play correctly. Great post. The gap between the bid and ask is already widening and that's not good for the shirts.

Early 2022, we were all expecting the newsletter of Feb. 29. Early Feb., the stock price jumped from 0.37$ to 0.47$ in a blink. Shorts got caught.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing